Tag Archive: NotreDameResearch

May 09

AY 2026 in Review: PD[N]ano Lab Highlights Featured in the Provost’s TPAC-RL May 2026 Newsletter

The Provost’s TPAC-RL Faculty Newsletter (Spring 2026) went out this week, and I’m grateful that several of the lab’s milestones from the past academic year were included in the round-up of faculty achievements. The newsletter is sent to the university’s Teaching, Professor of the Practice, Advising, Clinical, Research, and Library faculty community, and it’s a …

Continue reading »

May 09

Aurelie Brownsberger Leads a Student Cohort in a Journal of Nanotheranostics Invited Feature Review on Intrinsically Selective Therapeutic Nanoplatforms

I am thrilled to share that our invited Feature Review — led by graduate researcher Aurelie Brownsberger as lead author with significant contributions from undergraduate researchers in our group— is now published in MDPI’s Journal of Nanotheranostics (JNT), as part of the Special Issue: Feature Review Papers in Nanotheranostics. Title: Intrinsically Selective Nanoplatforms for Precision …

Continue reading »

Apr 28

Lab Family Dinner 2026: Celebrating Our Team and Sending Off Our Graduating Seniors

On the evening of April 28, 2026, about 18 of us from the PD[N]ano Lab gathered in McCourtney Hall (West) for our annual group dinner — easily one of the highlights of the academic year. We brought in takeout from Flavors of India here in South Bend, pulled up chairs around the conference table, and …

Continue reading »

Apr 24

Pitching MagSiNs at the IDEA Center’s Inaugural Research Commercialization Grant Event

On Friday, April 24, 2026, I had the privilege of being one of six Notre Dame faculty selected to pitch at the inaugural Research Commercialization Grant (RCG) Pitch Event, hosted by the IDEA Center at Notre Dame in Leighton Hall at Innovation Park. The morning brought together external investors, the IDEA Center Advisory Council, and …

Continue reading »

Mar 28

SFB 2026 in Atlanta: An Invited 30-Minute Talk on Antibiofilm Coatings, a Wound-Healing Poster, and an Oral Presentation from the Lab

The Society For Biomaterials (SFB) 2026 Annual Meeting & Exposition brought our lab to the Hyatt Regency Atlanta from March 25–28, 2026, and it was one of the most rewarding conferences for us this year. The lab had three contributions spanning our antibiofilm-coating, antimicrobial drug-delivery, and cancer-theranostic programs, and I was particularly honored to be …

Continue reading »

Mar 17

It’s Official: U.S. Patent No. 12,576,160 Issued for Our Bispecific Bridge Nanoparticle Technology

I am delighted to share that on March 17, 2026, the United States Patent and Trademark Office officially issued U.S. Patent No. 12,576,160 for our technology, “Bispecific bridge nanoparticles for efficient targeting of cancer cells using immunotherapy (universal CAR-T cells) or chemotherapeutic” (Notre Dame docket P21-043-US01). This is the same invention that received its Notice …

Continue reading »

Mar 10

A Busy Week in Raleigh: TechConnect World 2026 — Two Chaired Sessions, Two Oral Talks, and a BactiBlank Finalist Pitch

I had the privilege of representing the PD[N]ano Lab and the Berthiaume Institute for Precision Health at the 29th Annual TechConnect World Innovation Conference and Expo, held March 10–12, 2026 at the Raleigh Convention Center and the Raleigh Marriott City Center in Raleigh, North Carolina. It was a packed three days — between chairing sessions, …

Continue reading »

Feb 12

Invited Talk at the Innovation Sciences Seminar Series hosted at Rosalind Franklin University of Medicine and Science

I had a fantastic time visiting Rosalind Franklin University of Medicine and Science to speak at the Innovation Sciences Seminar Series hosted by the Center for Proteomics and Molecular Therapeutics (PMT) on February 12, 2026. It was a privilege to share my team’s work on “Label-Free Targeting of Therapeutics to Cancer Cells or Multi-Drug Resistant …

Continue reading »